Atenolol News and Research

RSS
Atenolol is a ß1 receptor specific antagonist, a drug belonging to the group of ß-blockers, a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and to treat and reduce the risk of heart complications following myocardial infarction (heart attack)
New reasons to avoid grapefruit juice when taking certain drugs

New reasons to avoid grapefruit juice when taking certain drugs

Significant gender differences in heart disease

Significant gender differences in heart disease

High blood pressure treatment effective in reversing vascular damage

High blood pressure treatment effective in reversing vascular damage

For hypertension patients, preventing or reducing enlarged heart may decrease risk for diabetes

For hypertension patients, preventing or reducing enlarged heart may decrease risk for diabetes

Memory tasks require more coordinated brain blood flow for people with high blood pressure

Memory tasks require more coordinated brain blood flow for people with high blood pressure

Reducing enlarged heart decreases risk of heart failure

Reducing enlarged heart decreases risk of heart failure

Preventing enlarged heart reduces heart failure

Preventing enlarged heart reduces heart failure

High blood pressure medication strategy proves effective in Hispanic women

High blood pressure medication strategy proves effective in Hispanic women

Caraco Pharmaceutical Labs announces FDA approval to market generic Tenormin

Caraco Pharmaceutical Labs announces FDA approval to market generic Tenormin

Ranbaxy granted approval to manufacture Atenolol

Ranbaxy granted approval to manufacture Atenolol

New tool to study protein kinase A - linked to heart failure

New tool to study protein kinase A - linked to heart failure

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

Diabetics benefit less from anti-hypertensive treatment to reduce enlarged heart

Diabetics benefit less from anti-hypertensive treatment to reduce enlarged heart

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Blood pressure near the heart is more predictive of cardiovascular outcomes than blood pressure measured in the arm

Norvasc better than beta blockers for lowering blood pressure

Norvasc better than beta blockers for lowering blood pressure

Beta blockers not as effective as other drugs that reduce high blood pressure in patients with hypertension

Beta blockers not as effective as other drugs that reduce high blood pressure in patients with hypertension

More doubt cast on benefit of beta blockers for high blood pressure

More doubt cast on benefit of beta blockers for high blood pressure

Strokes and heart attacks can be prevented in people with high blood pressure

Strokes and heart attacks can be prevented in people with high blood pressure

New blood pressure-lowering drugs reduce stroke risk by 50%

New blood pressure-lowering drugs reduce stroke risk by 50%

Guidelines for treatment of essential tremor

Guidelines for treatment of essential tremor